Therapy News and Research

RSS

The New York Times articles address harsh realities of what happens when addiction hits home

In Tuesday's health section of The New York Times, "When a Drug Addict Isn't Ready to Accept Help" and "In Business, Nondrinking Can Be a Costly Expense," both articles address the harsh realities of what happens when addiction hits home.

5 Oct 2012

Myocardial infarction mortality rates decrease by 44% over the last 15 years in Argentina

Mortality caused by myocardial infarction has decreased by 44% over the last 15 years in Argentina, according to new research which will be presented during the 38th Argentine Congress of Cardiology.

5 Oct 2012

Patients with eye diseases can benefit from ArtCornea

Blindness is often caused by corneal diseases. The established treatment is a corneal transplant, but in many cases this is not possible and donor corneas are often hard to come by. In the future, an artificial cornea could make up for this deficiency and save the vision of those affected.

5 Oct 2012

New book on natural interventions for lung cancer

Told he had lung cancer and 6 months to live, the author refused chemo/surgery and used holistic, natural, non-invasive interventions. Now, 38 years later at age 80 he not only beat the odds of lung cancer but also the odds of 3 chronic illnesses and 5 prescribed medications that are the average for a 75 year old.

5 Oct 2012

InsuPad device may improve insulin therapy

A novel device is currently under development for aiding insulin analog therapy in diabetes patients, report researchers.

4 Oct 2012

Age impacts salivary markers of oxidative stress, oral pathology

Age has a significant impact on the variance of salivary markers of oxidative stress, and could shed light on the pathogenesis of oral diseases, report Slovakian researchers.

4 Oct 2012

Stenting outcomes worse for elderly women than men

Results from a cohort study published in Cardiology show that elderly women have a higher risk for complications and in-hospital mortality immediately after treatment with either drug-eluting stents or bare metal stents than elderly men.

4 Oct 2012

Beta blockers do not lower cardiac risk in patients with or without CAD

Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.

4 Oct 2012

Hormone therapy offsets adverse metabolic effects of menopause

Long-term hormone therapy helps prevent the adverse metabolic effects that occur following menopause, research shows.

4 Oct 2012

Insulin degludec shows promise in diabetes

Self-administration of daily insulin degludag injections is no less effective than self-injecting insulin glargine in patients with diabetes who are new to insulin therapy, say researchers.

4 Oct 2012

New defibrillator offers advantages for young patients with congenital heart problems

A new ground-breaking technology was recently used at the University of Ottawa Heart Institute (UOHI) where two cardiologists, Dr. David Birnie and Dr. Pablo Nery, implanted a new innovative leadless defibrillator, the subcutaneous implantable cardioverter defibrillator (S-ICD), to a 18 year-old patient. Under Health Canada's special access program, this was only the third time this new type of ICD had been implanted in Canada.

4 Oct 2012

Krembil scientists develop lab study to accurately predict outcomes of stroke neuroprotectant

Scientists at the Krembil Neuroscience Centre, located at the Toronto Western Hospital, University Health Network have developed the first lab study in the world to accurately predict the outcomes of a human clinical for their drug that protects the brain against the damaging effects of stroke.

4 Oct 2012

Long-term survivors of hematopoietic cell transplants more likely to develop heart disease

New research appearing online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that long-term survivors of hematopoietic cell transplants (HCT) are at an increased risk of developing heart disease risk factors such as high blood pressure, diabetes, and high cholesterol when compared to the general population.

4 Oct 2012

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

A new study conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found using beta-blockers, the standard of care for patients with coronary artery disease (CAD), was not associated with a lower risk of heart attacks, death and strokes in patients suffering from CAD and those with risk factors for the disease, including those with a history of heart attack.

4 Oct 2012

Zimbabwe set to attain 'universal' ARV coverage

"Zimbabwe is set to attain 'universal' coverage for AIDS treatment thanks in part to an $84 million disbursement on Tuesday by the United Nations-backed Global Fund to Fight AIDS, Tuberculosis and Malaria," the U.N. News Centre reports.

4 Oct 2012

Premier, ArjoHuntleigh announce three-year contract for vascular compression therapy systems

ArjoHuntleigh announced today that it has been awarded a three-year contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its vascular compression therapy systems.

4 Oct 2012

Gender-specific group therapy effective in treating depressed women with Type 2 diabetes

Gender-specific group therapy is effective for treating depressed women with Type 2 diabetes, according to a study published in the latest issue of the Annals of Behavioral Medicine and funded by the National Institute of Nursing Research.

4 Oct 2012

Biceps tenodesis hastens recovery, cuts rehabilitation time for labrum tears

Athletics have always been a part of Jade Dismore's life. The 27-year-old native of South Africa grew up playing tennis and swimming; as an adult she became an avid runner and recreational volleyball player. For several years she felt soreness in her shoulder, but assumed it was nothing serious. As she began training for her first triathlon, the pain became increasingly severe. After trying to manage the pain on her own for years, Dismore decided it was time to seek medical attention.

4 Oct 2012

Mayo Clinic releases new app to help fight anxiety

Mayo Clinic is releasing an app this week for Apple iPhones, iPads and iPod Touch called Anxiety Coach, a self-help tool that assists people in reducing a variety of fears and worries ranging from extreme shyness to obsessions and compulsions.

4 Oct 2012

New type of drug for drug-resistant cancer

New drug may be an effective alternative for patients whose cancer is resistant to currently available drugs.

4 Oct 2012

Therapy News and Research

The New York Times articles address harsh realities of what happens when addiction hits home

Myocardial infarction mortality rates decrease by 44% over the last 15 years in Argentina

Patients with eye diseases can benefit from ArtCornea

New book on natural interventions for lung cancer

InsuPad device may improve insulin therapy

Age impacts salivary markers of oxidative stress, oral pathology

Stenting outcomes worse for elderly women than men

Beta blockers do not lower cardiac risk in patients with or without CAD

Hormone therapy offsets adverse metabolic effects of menopause

Insulin degludec shows promise in diabetes

New defibrillator offers advantages for young patients with congenital heart problems

Krembil scientists develop lab study to accurately predict outcomes of stroke neuroprotectant

Long-term survivors of hematopoietic cell transplants more likely to develop heart disease

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

Zimbabwe set to attain 'universal' ARV coverage

Premier, ArjoHuntleigh announce three-year contract for vascular compression therapy systems

Gender-specific group therapy effective in treating depressed women with Type 2 diabetes

Biceps tenodesis hastens recovery, cuts rehabilitation time for labrum tears

Mayo Clinic releases new app to help fight anxiety

New type of drug for drug-resistant cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News